What taking Wegovy actually looks like, from first pen to steady dose

Wegovy is injected once a week, on the same day each week, under the skin of the abdomen, thigh or upper arm — you rotate the site with each dose.
Treatment starts at 0.25 mg for the first four weeks; the dose is stepped up roughly every four weeks by your prescriber, not self-managed.
The most common effects are gastrointestinal (nausea in particular) and tend to peak in the days after a dose increase before settling.
Wegovy is a Black Triangle (▼) medicine in the UK, meaning the MHRA collects additional safety data; suspected side effects can be reported at yellowcard.mhra.gov.uk.

Taking Wegovy means committing to a once-weekly subcutaneous injection of semaglutide, titrated gradually from 0.25 mg to a maintenance dose of up to 2.4 mg (or the newer 7.2 mg pen, approved by the MHRA in April 2026), alongside a reduced-calorie diet and increased activity. It is a prescription-only medicine; a prescriber assesses your suitability before any treatment begins. Most people notice appetite reduction within the first few weeks, though the full effect builds over months as the dose increases. The NHS semaglutide medicines page covers what to expect in plain language and is worth reading before your first pen arrives.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How taking Wegovy works in practice: the schedule, the side effects, and when to ask for help

The week your pen arrives and what you do with it

Picture this: a plain, unbranded box turns up via DPD (tracked to your phone) and inside is a pre-filled Wegovy pen at 0.25 mg. That first pen is not a therapeutic dose in the way your maintenance dose will be. Its job is to let your body adjust to semaglutide with the least possible disruption. You inject once, note the day, and that day becomes your weekly injection day going forward.

The injection itself is subcutaneous — into the fatty tissue just under the skin. Abdomen, front of thigh or outer upper arm all work; the only rule is not to use the same spot twice running. Most people find a routine that fits: Sunday evening after dinner, Monday morning after the school run. Whatever lands naturally into your week tends to stick. The pen is pre-set, so there is no measuring or drawing up of liquid.

If you want a walkthrough of the physical process before you start, the guide to starting Wegovy covers technique, storage and that first injection in detail. Wegovy must be kept refrigerated at 2–8°C until use; the Patient Information Leaflet sets out the exact room-temperature window, and you should follow that rather than any general rule of thumb.

The dose schedule: why it takes months, not weeks, to reach full effect

Wegovy's titration schedule exists for a reason. Semaglutide slows gastric emptying and acts on appetite centres in the brain via GLP-1 receptors; ramping up too quickly amplifies the nausea, vomiting and digestive disruption that are this medicine's most common side effects. So the licensed pathway goes 0.25 mg for four weeks, then 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg, each step roughly a month apart, guided by your prescriber.

That means reaching the standard maintenance dose takes around five months minimum. The MHRA approved a higher 7.2 mg maintenance dose in April 2026, supplied via a dedicated single-dose pen; titration to that level takes longer still and is not right for everyone. Your prescriber decides whether and when to progress. Trying to accelerate the schedule yourself is one of the more reliable ways to spend a week feeling miserable without gaining anything therapeutically.

The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg dose. Results take time partly because the body responds cumulatively, not overnight. People taking Wegovy for weight loss often find that patience with the schedule pays back more than any shortcut would. If you are curious how the evidence stacks up for your goals, taking Wegovy for weight loss goes into the trial data in more depth.

Side effects to expect and the ones that mean stop and call someone

Nausea is the one most people mention. It tends to arrive in the first day or two after each dose increase and, for most, eases within a week or so as the body adjusts. Vomiting, loose stools, constipation, heartburn, burping and fatigue also appear on the list. These are not a sign the medicine is harming you; they reflect semaglutide's mechanism, slowing the gut, reducing appetite, changing how quickly food moves through your system.

Practical steps that genuinely help: eating smaller portions, going slower at mealtimes, avoiding very rich or fatty food around injection day, and keeping well hydrated. There is a longer set of practical tips for taking Wegovy if you want specifics.

Some symptoms require medical attention rather than watchful waiting. Severe stomach pain that spreads to the back (especially with vomiting) could indicate pancreatitis, which the MHRA highlighted in a January 2026 Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. Gallbladder symptoms, signs of a serious allergic reaction, or significant dehydration from persistent vomiting all warrant a call to your GP or 111, not a wait-and-see approach. The advice on what to do while taking Wegovy covers this in more detail, including when symptoms are routine and when they are not.

The questions about timing, missed doses and everyday logistics

Wegovy is taken once weekly; the day can be changed by a day or two if needed, provided the new injection is at least four days after the last one. A missed dose is not a reason to double up the following week. If the missed pen was less than five days ago, take it as soon as you remember and carry on from there; if more time has passed, skip it and resume your regular schedule. For anything beyond that general pattern, the Patient Information Leaflet and your prescriber are the right sources, missed-dose decisions depend on where you are in the titration, and a generalised answer online may not apply to your situation.

Some people find injecting at a consistent time of day helps them build the habit, and there is specific evidence-based thinking behind why some choose the evening; taking Wegovy at night looks at the reasoning. Others prefer mornings. The clinical answer is that timing within the day has no meaningful effect on efficacy, consistency across the week matters far more than the hour.

Wegovy is a prescription-only medicine and requires ongoing clinical oversight, not just a starting prescription. At nume, a GPhC-registered Independent Prescriber reads every consultation personally before any repeat is approved. There are no automatic renewals. If you are weighing up the overall picture of what private treatment involves, the Wegovy overview covers eligibility, cost context and NHS access alongside the clinical detail, and for a broader look at licensed options, the weight-loss treatments page is a good place to start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions